Free Trial
NYSE:ZEPP

Zepp Health (ZEPP) Stock Price, News & Analysis

Zepp Health logo
$37.54 +0.17 (+0.44%)
Closing price 03:59 PM Eastern
Extended Trading
$37.80 +0.27 (+0.72%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Zepp Health Stock (NYSE:ZEPP)

Key Stats

Today's Range
$36.35
$39.45
50-Day Range
$2.39
$43.17
52-Week Range
$2.13
$45.45
Volume
203,056 shs
Average Volume
666,853 shs
Market Capitalization
$544.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$60.23
Consensus Rating
Buy

Company Overview

Zepp Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

ZEPP MarketRank™: 

Zepp Health scored higher than 53% of companies evaluated by MarketBeat, and ranked 530th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Zepp Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Zepp Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Zepp Health's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zepp Health is -7.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zepp Health is -7.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Zepp Health has a P/B Ratio of 2.41. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.72% of the float of Zepp Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Zepp Health has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zepp Health has recently increased by 7.71%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Zepp Health does not currently pay a dividend.

  • Dividend Growth

    Zepp Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.72% of the float of Zepp Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Zepp Health has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Zepp Health has recently increased by 7.71%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Zepp Health has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Zepp Health this week, compared to 1 article on an average week.
  • Search Interest

    Only 4 people have searched for ZEPP on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Zepp Health to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zepp Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    36.00% of the stock of Zepp Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.61% of the stock of Zepp Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Zepp Health's insider trading history.
Receive ZEPP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zepp Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZEPP Stock News Headlines

Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.tc pixel
See More Headlines

ZEPP Stock Analysis - Frequently Asked Questions

Zepp Health's stock was trading at $2.60 on January 1st, 2025. Since then, ZEPP stock has increased by 1,343.7% and is now trading at $37.5360.

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) released its quarterly earnings data on Monday, May, 19th. The company reported ($1.13) EPS for the quarter. The business had revenue of $38.54 million for the quarter. Zepp Health had a negative trailing twelve-month return on equity of 24.19% and a negative net margin of 38.81%.
Read the conference call transcript
.

Shares of Zepp Health reverse split on Monday, September 16th 2024.The 1-4 reverse split was announced on Friday, September 6th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Top institutional shareholders of Zepp Health include Allspring Global Investments Holdings LLC (4.21%) and Group One Trading LLC.

Shares of ZEPP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zepp Health investors own include Nextera Energy Partners (NEP), NVIDIA (NVDA), PayPal (PYPL), Arista Networks (ANET), MercadoLibre (MELI), ASML (ASML).

Company Calendar

Last Earnings
5/19/2025
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Computer Hardware
Current Symbol
NYSE:ZEPP
CIK
1720446
Fax
N/A
Employees
1,230
Year Founded
N/A

Price Target and Rating

High Price Target
$60.23
Low Price Target
$60.23
Potential Upside/Downside
+58.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.83)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$75.73 million
Net Margins
-38.81%
Pretax Margin
-29.77%
Return on Equity
-24.19%
Return on Assets
-11.36%

Debt

Debt-to-Equity Ratio
0.31
Current Ratio
1.10
Quick Ratio
0.78

Sales & Book Value

Annual Sales
$182.60 million
Price / Sales
3.03
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$15.55 per share
Price / Book
2.45

Miscellaneous

Outstanding Shares
14,500,000
Free Float
9,279,000
Market Cap
$552.89 million
Optionable
Optionable
Beta
1.11
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:ZEPP) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners